Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial

EWER K., Frater J., LAMBE T., HILL A.

Type

Journal article

Publisher

Elsevier

Publication Date

2021-06-18T00:00:00+00:00

Permalink Close